Petros Pharmaceuticals Inc (PTPI)
0.677
+0.02
(+3.04%)
USD |
NASDAQ |
May 02, 16:00
0.765
+0.09
(+13.00%)
After-Hours: 20:00
Petros Pharmaceuticals Total Assets (Quarterly): 33.80M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.80M |
| September 30, 2023 | 38.91M |
| June 30, 2023 | 28.73M |
| March 31, 2023 | 30.57M |
| December 31, 2022 | 32.42M |
| September 30, 2022 | 37.70M |
| June 30, 2022 | 51.05M |
| Date | Value |
|---|---|
| March 31, 2022 | 55.86M |
| December 31, 2021 | 67.39M |
| September 30, 2021 | 52.04M |
| June 30, 2021 | 56.67M |
| March 31, 2021 | 66.15M |
| December 31, 2020 | 69.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.73M
Minimum
Jun 2023
69.85M
Maximum
Dec 2020
47.78M
Average
51.05M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 20.99M |
| Spectral AI Inc | 12.33M |
| Imunon Inc | 21.92M |
| Assembly Biosciences Inc | 136.82M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.32M |
| Shareholders Equity (Quarterly) | 12.48M |
| Debt to Equity Ratio | 0.6421 |
| Current Ratio | 1.893 |
| Net Debt Paydown Yield | 7.82% |